Emerge is the third Phase 3 study of MM120 ODT ... a 12-week, randomized, double-blind, placebo-controlled, parallel-group study assessing the efficacy and safety of a single dose of MM120 ...

Good morning. Welcome, everyone, to the Tamarack Valley Energy Limited Conference Call on Wednesday, May 7, 2025, discussing the recent Q1 2025 results press release.

Q1 2025 Earnings Call Transcript April 29, 2025 S&P Global Inc. beats earnings expectations. Reported EPS is $4.37, ...

Now while the Permian is not insulated ... with a 3.4 times I think on a credit agreement basis right now unadjusted just under 3.8. I mean this was a unanimous view from the Board, which was ...

Q1 2025 Earnings Call Transcript April 22, 2025 Iridium Communications Inc. beats earnings expectations. Reported EPS is ...

The Phase 3 development program for MM120 ODT in MDD is anticipated to include two pivotal clinical trials. The first, the 52-week Emerge study, will be conducted in two parts: Part A, a 12-week, ...

This phase 3, global, multicentre study included a screening period; a 24-week double-blind, placebo-controlled ... by the independent ethics committee or institutional review board. All patients ...

The results of the initial 24-week double-blind period of the KEEPsAKE 2 trial are reported here. This was a phase 3, global, multicentre study assessing ... An independent ethics ...

MADRID, SPAIN, May 4 (Reuters) - Kylian Mbappe scored two goals as Real Madrid fought off a late comeback attempt from Celta Vigo to secure a 3-2 win on Sunday and stay within four points of ...

This year, the Chhattisgarh Class 10 board examinations were conducted from March 3 to March 24, and Class 12 board exams from March 1 to March 28, 2025. Examinations for both classes were ...

Brock Burke (3-0), Los Angeles' fifth pitcher, got the win with one scoreless inning. With the score tied at 1, Ernie Clement opened the seventh with a double off Reid Detmers. Andres Gimenez beat ...